PRO 2000: next steps for microbicide development

被引：2
|
作者：
Karim, Salim S. Abdool [1 ,2 ]
Baxter, Cheryl [1 ]
机构：
[1] Univ KwaZulu Natal, CAPRISA, Durban, South Africa
[2] Columbia Univ, Dept Epidemiol, New York, NY 10027 USA
来源：
FUTURE VIROLOGY | 2009年 / 4卷 / 04期
关键词：
RANDOMIZED CONTROLLED-TRIAL; VAGINAL GEL; TRANSMISSION; HIV;
D O I：
10.2217/FVL.09.22
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：317 / 320
页数：4
相关论文
共 50 条
  • [11] Microbicides Development Programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention
    Andrew Nunn
    Sheena McCormack
    Angela M Crook
    Robert Pool
    Clare Rutterford
    Richard Hayes
    [J]. Trials, 10
  • [12] Tracking childhood development with MR: The next steps
    Ball, WS
    [J]. AMERICAN JOURNAL OF NEURORADIOLOGY, 1998, 19 (06) : 1005 - 1006
  • [13] Technological development in the next steps for the space colonization
    Gomez Arriagada, Hector Francisco
    [J]. REVISTA GESTION DE LAS PERSONAS Y TECNOLOGIA, 2013, 6 (17): : 58 - 65
  • [14] The development of the ITI® DENTAL IMPLANT SYSTEM -: Part 2.: 1998-2000:: Steps into the next millennium
    Scacchi, M
    Merz, BR
    Schär, AR
    [J]. CLINICAL ORAL IMPLANTS RESEARCH, 2000, 11 : 22 - 32
  • [15] Up-date on microbicide clinical trials for the Microbicide 2000 Conference
    Roddy, RE
    [J]. AIDS, 2001, 15 : S12 - S13
  • [16] Direct measurement of in-vivo vaginal microbicide levels of PRO 2000 achieved in a human safety study
    Lacey, CJN
    Wright, A
    Weber, JN
    Profy, AT
    [J]. AIDS, 2006, 20 (07) : 1027 - 1030
  • [17] Utility of colposcopy in a phase 2 portion of a microbicide clinical trial of BufferGel and 0.5% PRO 2000 Gel
    Chirenje, Zvavahera M.
    Masse, Benoit R.
    Maslankowski, Lisa A.
    Ramjee, Gita
    Coletti, Anne S.
    Tembo, Tchangani N.
    Magure, Tsitsi M.
    Soto-Torres, Lydia
    Kelly, Cliff
    Hillier, Sharon
    Karim, Abdool
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15
  • [18] The acceptability of an investigational vaginal microbicide, PRO 2000 gel, among women in a phase I clinical trial
    Morrow, K
    Rosen, R
    Richter, L
    Emans, A
    Forbes, A
    Day, J
    Morar, N
    Maslankowski, L
    Profy, AT
    Kelly, C
    Karim, SSA
    Mayer, KH
    [J]. JOURNAL OF WOMENS HEALTH, 2003, 12 (07) : 655 - 666
  • [19] A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women
    Van Damme, L
    Wright, A
    Depraetere, K
    Rosenstein, I
    Vandersmissen, V
    Poulter, L
    McKinlay, M
    Van Dyck, E
    Weber, J
    Profy, A
    Laga, M
    Kitchen, V
    [J]. SEXUALLY TRANSMITTED INFECTIONS, 2000, 76 (02) : 126 - 130
  • [20] Postcoital Bioavailability and Antiviral Activity of 0.5% PRO 2000 Gel: Implications for Future Microbicide Clinical Trials
    Keller, Marla J.
    Mesquita, Pedro M. M.
    Torres, N. Merna
    Cho, Sylvia
    Shust, Gail
    Madan, Rebecca P.
    Cohen, Hillel W.
    Petrie, Julie
    Ford, Tara
    Soto-Torres, Lydia
    Profy, Albert T.
    Herold, Betsy C.
    [J]. PLOS ONE, 2010, 5 (01):
12345